Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation

@article{Jaramillo2005ImmuneMI,
  title={Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation},
  author={Andr{\'e}s Jaramillo and Felix G. Fernandez and Elbert Y Kuo and Elbert P. Trulock and G Alec Patterson and Thalachallour Mohanakumar},
  journal={Pediatric Transplantation},
  year={2005},
  volume={9}
}
Abstract:  Lung transplantation is recognized as the only viable treatment option in a variety of end‐stage pulmonary diseases. However, the long‐term survival after lung transplantation is limited by the development of obliterative bronchiolitis, and its clinical correlate bronchiolitis obliterans syndrome (BOS), which is considered to represent chronic lung allograft rejection. Histopathologically, BOS is an inflammatory process that leads to fibrous scarring of the terminal and respiratory… 
Bronchiolitis obliterans syndrome: the final frontier for lung transplantation.
TLDR
A body of developing research is highlighted illustrating the mechanisms by which BOS is mediated, including alloimmune reactivity, the emerging roles of humoral and autoimmunity, activation of innate immune cells, and response to nonimmune-related allograft insults, such as infection and aspiration.
The Final Frontier for Lung Transplantation
TLDR
The body of developing research illustrating the mechanisms by which BOS is mediated, including alloimmune reactivity, the emerging roles of humoral and autoimmunity, activation of innate immune cells, and response to nonimmune-related allograft insults, such as infection and aspiration are highlighted.
Epithelial-mesenchymal transition: potential role in obliterative bronchiolitis?
TLDR
This study attempts to redefine traditional paradigms regarding normal airway epithelial biology and disease pathogenesis, and have the potential to lead to entirely new therapeutic avenues for previously untreatable disease processes such as BOS.
Elevated Soluble CD30 Correlates with Development of Bronchiolitis Obliterans Syndrome Following Lung Transplantation
TLDR
It is concluded that sCD30 may represent a novel marker to monitor the development of BOS, and it is investigated whether soluble CD30, a T-cell activation marker, would correlate with BOS.
Post-viral Bronchiolitis Obliterans
TLDR
Children with Bronchiolitis Obliterans have a highly and variable prognosis, with significant long-term morbidity reported in 78% to 92% of patients, depending on the etiology of the initial result.
Clopidogrel reduces post‐transplant obliterative bronchiolitis
  • R. Preidl, S. Eckl, S. Ensminger
  • Medicine, Biology
    Transplant international : official journal of the European Society for Organ Transplantation
  • 2013
TLDR
It is shown that platelet inhibition by clopidogrel as a single treatment and in combination with tacrolimus or everolimus reduced the development of fibrosis and obliteration in tracheal allografts.
Gene Expression Profiling in Murine Obliterative Airway Disease
Lung and heart‐lung transplantation are effective treatments for many diseases unresponsive to other therapy. However, long‐term survival of recipients is limited by the development of obliterative
Chronic Aspiration of Gastric Fluid Induces the Development of Obliterative Bronchiolitis in Rat Lung Transplants
  • B. Li, M. G. Hartwig, R. D. Davis
  • Medicine
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
  • 2008
TLDR
Experimental evidence linking chronic aspiration to the development of OB is provided and strategies aimed at preventing aspiration‐related injuries might improve outcomes in clinical lung transplantation are suggested.
Bronchiolitis obliterans in children
TLDR
BO is discussed as an entity that can follow any of several illnesses or toxic exposures, in addition to following allogeneic lung or bone marrow transplantation, and those research areas that require continuing efforts in order to prevent or treat this entity are described.
...
...

References

SHOWING 1-10 OF 97 REFERENCES
Bronchiolitis obliterans after human lung transplantation.
  • M. Estenne, M. Hertz
  • Medicine
    American journal of respiratory and critical care medicine
  • 2002
TLDR
Current concepts regarding post-transplant bronchiolitis obliterans are presented, including the recently updated classification system for bronchiola obliterans syndrome (BOS), an overview of current concepts regarding its pathogenesis and risk factors, potential surrogate markers that may contribute to early detection, and approaches to the management of this devastating complication.
Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria.
  • M. Estenne, J. Maurer, S. Yousem
  • Medicine
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
  • 2002
Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
TLDR
This study confirms that BOS is a major problem in lung transplantation, with a high incidence, rapid progression, and poor survival.
Human leukocyte antigen mismatches predispose to the severity of bronchiolitis obliterans syndrome after lung transplantation.
TLDR
The degree of HLA class I mismatching between donors and recipients predisposes lung transplant recipients to the development and severity of BOS.
Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant.
TLDR
Elevated bronchoalveolar lavage fluid neutrophil percentage as well as levels of the granulocyte activation markers myeloperoxidase and eosinophil cationic protein appear to be early signs of development of BOS in lung transplant recipients.
Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: role of IL-8.
TLDR
The novel observation that in lung transplant recipients with OB, neutrophilia is present and highly correlated with the presence of IL-8 is provided.
Insulinlike growth factor-1 in lung transplants with obliterative bronchiolitis.
TLDR
The data strongly argue for a role of IGF-1 and IGFBP-3 in the fibrotic process underlying BOS, and for their possible value as an early marker of this complication.
IL‐16 in the airways of lung allograft recipients with acute rejection or obliterative bronchiolitis
TLDR
Data are compatible with an increase in IL‐16 playing a protective role against AR but not against OB and, hypothetically, this type of protective effect could be exerted via a down‐regulation of the activity of T lymphocytes.
Different kinetics of obliterative airway disease development in heterotopic murine tracheal allografts induced by CD4+ and CD8+ T cells1
TLDR
Results show that both CD4+ and CD8+ T cells have a role in the pathogenesis of OAD and that natural killer cells and alloantibodies are not necessary for the development of this disease.
Transforming growth factor beta (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation.
  • A. el-Gamel, E. Sim, I. Hutchinson
  • Medicine, Biology
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
  • 1999
...
...